Sixteen years ago, the 13th International AIDS Conference (IAS) convened in Durban, South Africa, to “break the silence” on the millions of preventable AIDS-related deaths occurring around the world. The summit was notable as it laid out the clear case that HIV causes...
CHAI’s ARV Market Report provides a global perspective on the ARV marketplace in low- and middle-income countries in 2015 and outlines CHAI’s expectations on how the market will evolve over the next five years. See the ARV Market Report here.
In Malawi, innovative models have been developed to optimize the efficiency of HIV service delivery in order to scale up access to treatment. In particular, three key models of differentiated care have emerged: multi-month prescriptions; fast-track drug refills; and...
Aurobindo Pharma Limited is pleased to announce the tentative approval of Dolutegravir 50mg from US Food & Drug Administration (USFDA) for the treatment of HIV. This important milestone marks the first FDA approval of a generic version of Dolutegravir (DTG), an...
The Clinton Health Access Initiative, Inc. (“CHAI”) was founded in 2002 as a Clinton Foundation Initiative. Today, the CHAI Board of Directors, which is fully committed to and proud of CHAI’s life-saving work, announced the following changes will be implemented if...
